BRPI0510893A - composição, composição cosmética ou dermatológica, processo de preparação de uma composição e uso de uma composição - Google Patents
composição, composição cosmética ou dermatológica, processo de preparação de uma composição e uso de uma composiçãoInfo
- Publication number
- BRPI0510893A BRPI0510893A BRPI0510893-4A BRPI0510893A BRPI0510893A BR PI0510893 A BRPI0510893 A BR PI0510893A BR PI0510893 A BRPI0510893 A BR PI0510893A BR PI0510893 A BRPI0510893 A BR PI0510893A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- cosmetic
- preparing
- dermatological
- glycol
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 239000002537 cosmetic Substances 0.000 title abstract 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 abstract 1
- 229960005084 calcitriol Drugs 0.000 abstract 1
- 235000020964 calcitriol Nutrition 0.000 abstract 1
- 239000011612 calcitriol Substances 0.000 abstract 1
- 229960004703 clobetasol propionate Drugs 0.000 abstract 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/04—Manufacture or treatment of semiconductor devices or of parts thereof the devices having potential barriers, e.g. a PN junction, depletion layer or carrier concentration layer
- H01L21/18—Manufacture or treatment of semiconductor devices or of parts thereof the devices having potential barriers, e.g. a PN junction, depletion layer or carrier concentration layer the devices having semiconductor bodies comprising elements of Group IV of the Periodic Table or AIIIBV compounds with or without impurities, e.g. doping materials
- H01L21/20—Deposition of semiconductor materials on a substrate, e.g. epitaxial growth solid phase epitaxy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Manufacturing & Machinery (AREA)
- Dispersion Chemistry (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Computer Hardware Design (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Power Engineering (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
COMPOSIçãO, COMPOSIçãO COSMéTICA OU DERMATOLóGICA, PROCESSO DE PREPARAçãO DE UMA COMPOSIçãO E USO DE UMA COMPOSIçãO A presente invenção trata de uma composição que contém dois ativos dissolvidas, o calcitriol e o 17-propionato de clobetasol, de seus usos em cosmética e dermatologia, bem como de seu processo de preparação, caracterizada pelo fato da composição ser uma emulsão inversa que contém uma fase hidrófila dispersada glicólica ou hidroglicólica, uma fase contínua lipófila e um emulsionante de HLB compreendido entre 2 e 7.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0406612A FR2871699A1 (fr) | 2004-06-17 | 2004-06-17 | Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie |
PCT/FR2005/001495 WO2006005843A1 (fr) | 2004-06-17 | 2005-06-15 | Composition de type emulsion inverse contenant du calcitriol et du 17 proprionate de clobetasol, et ses utilisations en cosmetique et en dermatologie |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0510893A true BRPI0510893A (pt) | 2007-11-27 |
Family
ID=34946892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0510893-4A BRPI0510893A (pt) | 2004-06-17 | 2005-06-15 | composição, composição cosmética ou dermatológica, processo de preparação de uma composição e uso de uma composição |
Country Status (15)
Country | Link |
---|---|
US (1) | US20050281850A1 (pt) |
EP (1) | EP1758591B2 (pt) |
JP (1) | JP2008502662A (pt) |
KR (1) | KR20070028424A (pt) |
CN (1) | CN1972693A (pt) |
AT (1) | ATE375161T1 (pt) |
AU (1) | AU2005261570A1 (pt) |
BR (1) | BRPI0510893A (pt) |
CA (1) | CA2567682A1 (pt) |
DE (1) | DE602005002844T3 (pt) |
ES (1) | ES2296218T5 (pt) |
FR (1) | FR2871699A1 (pt) |
MX (1) | MXPA06014406A (pt) |
RU (1) | RU2007101539A (pt) |
WO (1) | WO2006005843A1 (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
JP5612263B2 (ja) * | 2005-06-01 | 2014-10-22 | スティーフェル リサーチ オーストラリア ピーティーワイ リミテッド | ビタミン製剤 |
US20090041694A1 (en) * | 2005-09-22 | 2009-02-12 | Reinhard Pinzer | Preparation, in particular cosmetic preparation, production and use thereof |
FR2903602B1 (fr) * | 2006-07-12 | 2012-10-26 | Seppic Sa | Formulation injectable a liberation prolongee de principes actifs, procede pour sa preparation |
BRPI0715636A2 (pt) * | 2006-08-29 | 2013-07-02 | Teva Pharma | composiÇÕes farmacologicamente ativas estÁveis incluindo compostos contendo vitamina d e corticosteràide com compatibilidade para ph baixo |
EP1970048A1 (en) * | 2007-03-15 | 2008-09-17 | Drug Delivery Solutions Limited | Polyaphron topical composition with vitamin D |
US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
EP2008651A1 (en) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A bioerodible patch |
WO2010072958A2 (fr) * | 2008-12-23 | 2010-07-01 | Galderma S.A. | Composition pharmaceutique topique comprenant un principe actif sensible a l'eau |
HUE045467T2 (hu) | 2011-03-14 | 2020-01-28 | Drug Delivery Solutions Ltd | Szemészeti készítmény |
JP6093007B2 (ja) * | 2012-04-27 | 2017-03-08 | ダウ コーニング コーポレーションDow Corning Corporation | 基質に有効成分を送達するためのシリコーン系賦形剤を含有する局所用製剤組成物 |
JP6267218B2 (ja) * | 2012-11-06 | 2018-01-24 | ロチャル インダストリーズ,エルエルシー | 揮発性、疎水性溶媒を用いた生物学的に活性な薬剤の送達 |
EP3055349A1 (en) | 2013-10-11 | 2016-08-17 | Bewi Styrochem Oy | Polystyrene beads with low thermal conductivity |
US20160184431A1 (en) * | 2014-03-11 | 2016-06-30 | Promius Pharma Llc | Topical compositions comprising a corticosteroid |
BR112017008815A2 (pt) * | 2014-10-31 | 2018-03-27 | Shiseido Co Ltd | cosmético protetor solar de emulsão água em óleo. |
WO2017037663A1 (en) | 2015-09-02 | 2017-03-09 | Cadila Healthcare Limited | Topical compositions comprising corticosteroids |
FR3062059B1 (fr) * | 2017-01-26 | 2020-08-28 | Laboratoires M&L | Base de formulation cosmetique concentree description |
KR20200092940A (ko) * | 2017-10-06 | 2020-08-04 | 유니베르시떼 드 보르도 | 신규한 폴리머 유화제 및 소수성 또는 친수성 활성 화합물의 캡슐화를 위한 그의 용도 |
EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
JP2021529811A (ja) * | 2018-07-11 | 2021-11-04 | クレキシオ バイオサイエンシーズ エルティーディー. | 局所用デトミジン製剤 |
CN109833291B (zh) * | 2019-04-03 | 2022-08-26 | 普霖贝利生物医药研发(上海)有限公司 | 一种稳定的丙酸氯倍他索软膏及其制备方法 |
WO2021046444A1 (en) * | 2019-09-06 | 2021-03-11 | Encore Dermatology, Inc. | Topical compositions comprising a corticosteroid for the treatment of psoriasis in pediatric patients |
IT201900020526A1 (it) * | 2019-11-07 | 2021-05-07 | Francesco Leva | Formulazione trifasica emulsionabile e suoi impieghi terapeutici e/o cosmetologici |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863725A (en) * | 1982-10-27 | 1989-09-05 | Deckner George E | Novel clear oil-free moisturizer composition |
US4610978A (en) * | 1983-03-22 | 1986-09-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same |
US5898037A (en) * | 1992-11-13 | 1999-04-27 | Marx; Alvin J. | Formulations of magnesium compounds for local application and methods of treatment using the same |
US6348199B1 (en) * | 1993-03-24 | 2002-02-19 | Joseph Vernice | Skin treatment cream |
FR2742354B1 (fr) * | 1995-12-15 | 1998-01-23 | Oreal | Emulsion e/h/e stable contenant un actif cosmetique et/ou dermatologique sensible a l'eau |
FR2753626B1 (fr) * | 1996-09-20 | 1998-11-06 | Centre International De Rech Dermatologiques Galderma Cird Galderma | Nouvelles compositions topiques sous forme d'emulsion fluide h/e a forte teneur en glycol pro-penetrant |
RO118174B1 (ro) * | 1997-08-21 | 2003-03-28 | Aventis Pharma Deutschland Gmbh | Lac de unghii şi utilizarea acestuia |
US20010002396A1 (en) * | 1998-07-16 | 2001-05-31 | Charles Achkar | Compositions and methods of treating skin conditions |
PT1178808E (pt) * | 1999-04-23 | 2012-08-16 | Leo Pharma As | Composição farmacêutica não aquosa para utilização dérmica para o tratamento da psoríase compreendendo uma vitamina d, um corticosteróide e de um componente solvente |
US6762158B2 (en) * | 1999-07-01 | 2004-07-13 | Johnson & Johnson Consumer Companies, Inc. | Personal care compositions comprising liquid ester mixtures |
KR100317935B1 (ko) * | 1999-10-20 | 2001-12-22 | 유승필 | 대사성 골질환 치료용 약제조성물 및 이의 제조방법 |
FR2828100B1 (fr) * | 2001-08-02 | 2004-09-24 | Galderma Res & Dev | Composition de type emulsion inverse contenant de la dhea et/ou ses precurseurs ou derives, et ses utilisations en cosmetique et en dermatologie |
DE10154627A1 (de) * | 2001-11-07 | 2003-05-15 | Beiersdorf Ag | Kosmetische oder dermatologische getränkte Tücher |
US6797685B2 (en) * | 2002-04-26 | 2004-09-28 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Liquid laundry detergent with emulsion layer |
CA2505406A1 (en) * | 2002-12-17 | 2004-07-01 | Galderma Sa | Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate |
BRPI0406490A (pt) * | 2003-02-05 | 2005-12-06 | Galderma Res & Dev | Composições, composição cosmética ou dermatológica e uso de uma composição |
-
2004
- 2004-06-17 FR FR0406612A patent/FR2871699A1/fr active Pending
- 2004-09-21 US US10/944,887 patent/US20050281850A1/en not_active Abandoned
-
2005
- 2005-06-15 KR KR1020067026569A patent/KR20070028424A/ko not_active Application Discontinuation
- 2005-06-15 MX MXPA06014406A patent/MXPA06014406A/es not_active Application Discontinuation
- 2005-06-15 WO PCT/FR2005/001495 patent/WO2006005843A1/fr active IP Right Grant
- 2005-06-15 CA CA002567682A patent/CA2567682A1/fr not_active Abandoned
- 2005-06-15 DE DE602005002844T patent/DE602005002844T3/de active Active
- 2005-06-15 AT AT05777134T patent/ATE375161T1/de not_active IP Right Cessation
- 2005-06-15 AU AU2005261570A patent/AU2005261570A1/en not_active Abandoned
- 2005-06-15 RU RU2007101539/15A patent/RU2007101539A/ru unknown
- 2005-06-15 ES ES05777134T patent/ES2296218T5/es active Active
- 2005-06-15 BR BRPI0510893-4A patent/BRPI0510893A/pt not_active Application Discontinuation
- 2005-06-15 CN CNA2005800200897A patent/CN1972693A/zh active Pending
- 2005-06-15 EP EP05777134A patent/EP1758591B2/fr active Active
- 2005-06-15 JP JP2007515997A patent/JP2008502662A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CN1972693A (zh) | 2007-05-30 |
EP1758591B1 (fr) | 2007-10-10 |
ATE375161T1 (de) | 2007-10-15 |
MXPA06014406A (es) | 2007-02-19 |
KR20070028424A (ko) | 2007-03-12 |
DE602005002844D1 (de) | 2007-11-22 |
AU2005261570A1 (en) | 2006-01-19 |
EP1758591A1 (fr) | 2007-03-07 |
WO2006005843A1 (fr) | 2006-01-19 |
EP1758591B2 (fr) | 2010-12-15 |
ES2296218T3 (es) | 2008-04-16 |
JP2008502662A (ja) | 2008-01-31 |
RU2007101539A (ru) | 2008-07-27 |
ES2296218T5 (es) | 2011-05-05 |
US20050281850A1 (en) | 2005-12-22 |
DE602005002844T2 (de) | 2008-07-10 |
FR2871699A1 (fr) | 2005-12-23 |
CA2567682A1 (fr) | 2006-01-19 |
DE602005002844T3 (de) | 2011-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0510893A (pt) | composição, composição cosmética ou dermatológica, processo de preparação de uma composição e uso de uma composição | |
BRPI0511206A (pt) | composição farmacêutica anidra e uso de um ungüento oleaginoso | |
CY1108659T1 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν ενα αμφοτερικο επιφανειοδραστικο, μια πολυπροποξυλιωμενη κετυλικη αλκοολη και μια πολικη φαρμακευτικη ουσια | |
BRPI0508525A (pt) | concentrados de suspensão em base de óleo | |
ATE352276T1 (de) | Mikro-emulsionen mit binärer phasen- und wirkstoffdifferenzierbarkeit, deren herstellung und deren verwendung, insbesondere zur topischen sauerstoffversorgung | |
BR9915963A (pt) | Emulsão óleo em água cosmética ou para o cuidado pessoal, método de produção de uma emulsão, formulação de estabilizador de emulsificante de mistura seca, mistura seca, e, uso de uma combinação de polissacarìdeo, de um polissacarìdeo de xantano e de um polissacarìdeo de poliglucomanano | |
FR2788007B1 (fr) | Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique | |
BRPI0415397A (pt) | métodos e reagentes para o tratamento de desordens imunoinflamatórias | |
FR2826292B1 (fr) | Emulsions huile dans huile comprenant une silicone, dispersions de telles emulsions et utilisation | |
BR0107695A (pt) | Tratamento de dano cerebral, espinhal e a nervos | |
DE602004027047D1 (de) | Mechanisches inversionsverfahren zur herstellung von silikon-öl-in-wasser-emulsionen | |
CY1112217T1 (el) | Καλλυντικο προϊον που απορροφα τον ιδρωτα και μεθοδος για την παρασκευη του | |
AR032415A1 (es) | Producto para el modelado del cabello, de doble fase, que brinda beneficios de modelado y acondicionamiento | |
DE59913995D1 (de) | Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl | |
KR870000072A (ko) | 아졸 유도체를 함유하는 제제물 및 외상없이 손톱을 제거하기 위한 그 용도 | |
ATE275393T1 (de) | Feste dispersionen mit nitrataktiven wirkstoffen | |
EP1291010A3 (de) | Kosmetische und dermatologische Zubereitungen in Form von O/W-Emulsionen, enthaltend ein aminosubstituiertes Hydroxybenzophenon | |
WO2007053647A3 (en) | Cosmetic skincare applications employing mineral-derived tubules for controlled release | |
BRPI0416311A (pt) | composição, uso de uma composição e processo para melhorar a penetração de um agente ativo farmacêutico | |
ATE525110T1 (de) | Inverse emulsionszusammensetzung mit ivermectin und verwendung davon in der kosmetik und in der dermatologie | |
ES2176021T3 (es) | Extracto de mirto, procedimiento de preparacion y aplicacion. | |
ES2030494T3 (es) | Composicion de una fase conteniendo un aceite perfluorado y uno o varios agentes superficiactivos, util como excipiente para formulaciones cosmeticas y dermatologicas, asi como para aplicaciones biomedicinales. | |
BR0318343A (pt) | composição tópica para administração transdérmica | |
ATE229808T1 (de) | Kosmetische oder dermatologische zubereitungen, enthaltend peroxidlipide und organosiliziumverbindungen und verwendung derselben | |
PT1893237E (pt) | Composição farmacêutica compreendendo um elastómero organopolissiloxano e um princípio activo solubilizado |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |